Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature.

Q4 Medicine

Case Reports in Pulmonology Pub Date : 2020-06-14 eCollection Date: 2020-01-01 DOI:10.1155/2020/1090629

Amr Essa, Jeffrey Macaraeg, Nikhil Jagan, Daniel Kwon, Saboor Randhawa, Matthew Kruse, Stanley Thomas, Manasa Velagapudi, John Horne, Shraddha Narechania, Michael Kaster, Carrie Valenta, Venketraman Sahasranaman, Douglas Moore

{"title":"Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature.","authors":"Amr Essa, Jeffrey Macaraeg, Nikhil Jagan, Daniel Kwon, Saboor Randhawa, Matthew Kruse, Stanley Thomas, Manasa Velagapudi, John Horne, Shraddha Narechania, Michael Kaster, Carrie Valenta, Venketraman Sahasranaman, Douglas Moore","doi":"10.1155/2020/1090629","DOIUrl":null,"url":null,"abstract":"<p><p>Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.</p>","PeriodicalId":52364,"journal":{"name":"Case Reports in Pulmonology","volume":"2020 ","pages":"1090629"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/1090629","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Pulmonology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/1090629","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 4

Abstract

Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.

Abstract Image

查看原文本刊更多论文

电子烟或电子烟产品使用相关肺损伤(EVALI)病例回顾及文献综述

自从21世纪初电子烟出现以来，它的产业、受欢迎程度和流行程度都急剧上升。在过去，电子烟与尼古丁或大麻产品的雾化一起使用与一些肺损伤病例有关。然而，在2019年，美国报告了数千起与电子烟或电子烟产品使用相关的肺损伤(EVALI)病例。有证据表明，此次疫情与吸食四氢大麻酚(THC)有关。我们报告两例确诊的EVALI及其相关的临床、放射学和病理特征。这份报告支持了关于EVALI的越来越多的信息。它还讨论了各种物质，特别是维生素E醋酸酯，它被认为是一种病原体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊